|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.20 EUR | -0.76% |
|
-1.50% | -5.76% |
| 05-29 | HAEMATO AG announces Annual dividend, payable on July 10, 2026 | CI |
| 01-31 | PHOENIX Pharmahandel SE completed the acquisition of HAEMATO Pharm GmbH from HAEMATO AG. | CI |
| Market Cap | 67.96M 77.69M 62.68M 57.89M 110M 7.41B 112M 749M 294M 3.65B 292M 285M 12.55B | P/E 2023 * |
-
| P/E 2024 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 67.96M 77.69M 62.68M 57.89M 110M 7.41B 112M 749M 294M 3.65B 292M 285M 12.55B | EV / Sales 2023 * |
-
| EV / Sales 2024 * | - |
| Free-Float |
99.67% | Yield 2023 * |
-
| Yield 2024 * | - |
| 1 day | -0.76% |
| Manager | Title | Age | Since |
|---|---|---|---|
Patrick Brenske
CEO | Chief Executive Officer | - | 30/11/2020 |
Attila Strauss
PRN | Corporate Officer/Principal | - | 01/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrea Grosse
CHM | Chairman | 61 | 30/05/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.76% | -1.50% | - | - | 78.28M | |
| -1.22% | -4.65% | +47.04% | +12.35% | 309B | |
| +0.07% | -4.09% | +22.06% | -4.22% | 69.38B | |
| -3.08% | -4.09% | +32.22% | +104.18% | 9.33B | |
| -1.23% | -0.84% | +6.26% | +1.52% | 8.62B | |
| +2.74% | -4.41% | -16.77% | +12.26% | 4.16B | |
| +1.60% | -9.66% | +14.44% | +27.14% | 4.01B | |
| +1.63% | -2.70% | -38.89% | +27.08% | 3.33B | |
| -0.59% | +0.85% | +46.23% | +62.45% | 2.83B | |
| +2.24% | -2.33% | +11.41% | -21.98% | 2.09B | |
| Average | +0.14% | -1.96% | +13.78% | +24.53% | 45.85B | |
| Weighted average by Cap. | -0.93% | -3.36% | +39.81% | +11.85% |
| 2023 * | 2024 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- HAEK Stock
- HAE Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
